Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Thrombocytopenia

Explore clinical trials studying Primary Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

27 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Thrombocytopenia trial results

Not yet recruiting

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT07083739

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The first affiliated hospital of ustc anhui provincial hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Chaoyang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 51 locations
View Trial Details
Active, not recruiting

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

NCT05653219

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • NorthShore University Health System Evanston, Illinois, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 74 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04812925

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Bentonville, Arkansas, United States
  • Investigator site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010062 Fort Wayne, Indiana, United States
  • Investigator site US0010042 Iowa City, Iowa, United States
View all 83 locations
View Trial Details
Active, not recruiting

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT05325593

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • IRCCS AOU di Bologna, Seràgnoli Institute of Hematology Bologna, Italy
  • ASST Fatebenefratelli Sacco - Ospedale L. Sacco Milan, Italy
  • Grande Ospedale Metropolitano Niguarda Milan, Italy
  • Azienda Ospedaliero-Universitaria Policlinico Umberto I / SAPIENZA Universitá di Roma Rome, Italy
View all 30 locations
View Trial Details
Completed

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010037 Ocala, Florida, United States
  • Investigator Site 0010042 Iowa City, Iowa, United States
  • Investigator Site 0010040 Columbus, Ohio, United States
View all 87 locations
View Trial Details
Completed

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

NCT06665308

Conditions
Adult Immune Thrombocytopenia, Autoimmune Diseases, Blood Coagulation Disorders, +18 more
Locations
  • USC Norris Comprehensive Cancer Center- Site Number : 8400002 Los Angeles, California, United States
  • Massachusetts General Hospital- Site Number : 8400001 Boston, Massachusetts, United States
  • University of Washington-Fred Hutchinson Cancer Center_Site Number: 8400003 Seattle, Washington, United States
  • Investigational Site Number: 8260001 London, London, City of, United Kingdom
View Trial Details
Completed

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

NCT04278924

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Arizona Clinical Research Center - Hunt - PPDS Tucson, Arizona, United States
  • University of Florida Gainesville, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04188379

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010038 Tucson, Arizona, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010034 Jacksonville, Florida, United States
  • Investigator site 0010037 Ocala, Florida, United States
View all 121 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04687072

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Springdale, Arkansas, United States
  • Investigator site 0010036 Los Angeles, California, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010104 Weston, Florida, United States
View all 200 locations
View Trial Details

Related conditions